2020 News Releases
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
LOS ANGELES, Calif., Feb. 7, 2020 - Puma Biotechnology, Inc. (NASDAQ: PBYI), a
biopharmaceutical company, announced that on February 5, 2020 the Compensation Committee of
Pumaâ€™s Board of Directors approved the grant of inducement restricted stock unit awards covering an
aggregate of 78,875 shares of Puma common stock to 14 new non-executive employees.
The awards were granted under Pumaâ€™s 2017 Employment Inducement Incentive Award Plan, which was
adopted on April 27, 2017 and provides for the granting of equity awards to new employees of Puma. The
restricted stock unit awards vest over a three-year period, with one-third of the shares underlying each
award vesting on the first anniversary of the awardâ€™s vesting commencement date, February 1, 2020, and
one-sixth of the shares underlying each award vesting on each six-month anniversary of the vesting
commencement date thereafter, subject to continued service. The awards were granted as an inducement
material to the new employees entering into employment with Puma, in accordance with Nasdaq Listing
Puma Biotechnology, Inc.